www.nasdaq.com/de/symbol/kmph/real-time
Aktuell: $4.8899
*
0.5799
13.45%
|
25 Mio. $ Offering
"CORALVILLE, Iowa, Oct. 05, 2018 -- KemPharm, Inc., a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the pricing of its underwritten public offering of 8,333,334 shares of its common stock at a price to the public of $3.00 per share. In addition, KemPharm has granted to the underwriters a 30-day option to purchase up to 1,250,000 additional shares of common stock at the public offering price, less the underwriting discount. The offering is expected to close on or about October 10, 2018, subject to customary closing conditions."
investors.kempharm.com/news-releases/...-offering-common-stock
Kempharm meldet Zahlen für 2018
investors.kempharm.com/news-releases/...q4-and-fy-2018-results
seekingalpha.com/news/...nt-hours-kp415-nda-nears-finish-line
Nasdaq Delisting
www.sec.gov/Archives/edgar/data/1434647/...mph20200519_8k.htm
50 Mio. $ Offering und Nasdaq Listing
seekingalpha.com/news/...ty-trading-on-nasdaq-kicks-off-today
FDA Zulassung für Azstarys (ADHD)
www.benzinga.com/general/biotech/21/03/...or-azstarys-in-adhd
Wie so oft: Buy the rumor, sell the fact! Vlt wird im Hintergrund auch schon am nächsten Offering gestrickt...
$KMPH Key take aways.
1. 132 mil in cash with 1.5 mil/Quarter burn rate
2. Scripts written for both Apadaz and Azstarys. And expanding. Might not be huge but next earnings we have drug revenue.
3. Gonna have a bunch of data on SDX soon and what it could do.
4. They are open to acquisitions and licensing internal products.
5. They plan on being a multi billion dollar company.
6. No current plan for dilution but open if it drives value.
7. Should be getting more analysis on stock soon.
All I smell is Money. May take a few months but we will soon be rewarded for holding. Tutes are gonna want in.
KemPharm kauft Assets von Orphazyme
investors.kempharm.com/news-releases/...arimoclomol-orphazyme
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
67 | KEMPHARM a buy ? | Balu4u | Vassago | 22.02.23 15:00 |